Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

NCT00017927 is registered in ClinicalTrials.gov with National Institute of Dental and Craniofacial Research (NIDCR) as lead sponsor.

NCT NCT00017927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
June 30, 2005
Enrollment
10
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mccune albright syndrome, polyostotic fibrous dysplasia